City Hill Ventures
Contact Us  
Home About Us Team News
 
   
 

News and Events

Ignyta Announces Initiation of STARTRK-1 Global Phase I/II Clinical Trial of RXDX-101

7.21.14 press release

 
 
 
   
 
© 2010 City Hill Ventures, LLC Home    About Us    Team    Portfolio    News    Contact Us
 
Learn More